{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T12:10:48Z","timestamp":1683202248311},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T00:00:00Z","timestamp":1126569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s00262-005-0076-8","type":"journal-article","created":{"date-parts":[[2005,9,12]],"date-time":"2005-09-12T07:34:46Z","timestamp":1126510486000},"page":"861-866","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic efficacy of tumor-targeted IL2 in LT\u03b1\u2212\/\u2212 mice depends on conditioned T cells"],"prefix":"10.1007","volume":"55","author":[{"given":"David","family":"Schrama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas O.","family":"Eggert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph A.","family":"Reisfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,9,13]]},"reference":[{"key":"76_CR1","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood.V101.4.1477","volume":"101","author":"K Abe","year":"2003","unstructured":"Abe K, Yarovinsky FO, Murakami T, Shakhov AN, Tumanov AV, Ito D, Drutskaya LN, Pfeffer K, Kuprash DV, Komschlies KL, Nedospasov SA (2003) Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo. Blood 101: 1477\u20131483","journal-title":"Blood"},{"key":"76_CR2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","volume":"5","author":"J Banchereau","year":"2005","unstructured":"Banchereau J, Palucka AK (2005) Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5:296\u2013306","journal-title":"Nat Rev Immunol"},{"key":"76_CR3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4049\/jimmunol.155.4.1685","volume":"155","author":"TA Banks","year":"1995","unstructured":"Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, Bouley DM, Thomas J, Kanangat S, Mucenski ML (1995) Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 155:1685\u20131693","journal-title":"J Immunol"},{"key":"76_CR4","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1084\/jem.183.5.2361","volume":"183","author":"JC Becker","year":"1996","unstructured":"Becker JC, Pancook JD, Gillies SD, Furukawa K, Reisfeld RA (1996) T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy. J Exp Med 183:2361\u20132366","journal-title":"J Exp Med"},{"key":"76_CR5","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00007890-200201151-00005","volume":"73","author":"C Caux","year":"2002","unstructured":"Caux C, Vanbervliet B, Massacrier C, Ait-Yahia S, Vaure C, Chemin K, Dieu-Nosjean M, Vicari A (2002) Regulation of dendritic cell recruitment by chemokines. Transplantation 73:S7\u2013S11","journal-title":"Transplantation"},{"key":"76_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.174.1.21","volume":"174","author":"T Cupedo","year":"2005","unstructured":"Cupedo T, Mebius RE (2005) Cellular interactions in lymph node development. J Immunol 174:21\u201325","journal-title":"J Immunol"},{"key":"76_CR7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.8171322","volume":"264","author":"P De Togni","year":"1994","unstructured":"De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703\u2013707","journal-title":"Science"},{"key":"76_CR8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1521-4141(200201)32:1<122::AID-IMMU122>3.0.CO;2-C","volume":"32","author":"AO Eggert","year":"2002","unstructured":"Eggert AO, Becker JC, Ammon M, McLellan AD, Renner G, Merkel A, Brocker EB, Kampgen E (2002) Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture. Eur J Immunol 32:122\u2013127","journal-title":"Eur J Immunol"},{"key":"76_CR9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/hyb.1991.10.347","volume":"10","author":"SD Gillies","year":"1991","unstructured":"Gillies SD, Young D, Lo KM, Foley SF, Reisfeld RA (1991) Expression of genetically engineered immunoconjugates of lymphotoxin and a chimeric anti-ganglioside GD2 antibody. Hybridoma 10:347\u2013356","journal-title":"Hybridoma"},{"key":"76_CR10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/bc00021a008","volume":"4","author":"SD Gillies","year":"1993","unstructured":"Gillies SD, Young D, Lo KM, Roberts S (1993) Biological activity and in vivo clearance of antitumor antibody\/cytokine fusion proteins. Bioconjug Chem 4:230\u2013235","journal-title":"Bioconjug Chem"},{"key":"76_CR11","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1073\/pnas.91.22.10455","volume":"91","author":"M Haraguchi","year":"1994","unstructured":"Haraguchi M, Yamashiro S, Yamamoto A, Furukawa K, Takamiya K, Lloyd KO, Shiku H (1994) Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8- sialyltransferase cDNA using anti-GD2 monoclonal antibody. Proc Natl Acad Sci USA 91:10455\u201310459","journal-title":"Proc Natl Acad Sci USA"},{"key":"76_CR12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.bjc.6601267","volume":"89","author":"C Heuser","year":"2003","unstructured":"Heuser C, Ganser M, Hombach A, Brand H, Denton G, Hanisch FG, Abken H (2003) An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells. Br J Cancer 89:1130\u20131139","journal-title":"Br J Cancer"},{"key":"76_CR13","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1073\/pnas.96.11.6336","volume":"96","author":"K Iizuka","year":"1999","unstructured":"Iizuka K, Chaplin DD, Wang Y, Wu Q, Pegg LE, Yokoyama WM, Fu YX (1999) Requirement for membrane lymphotoxin in natural killer cell development. Proc Natl Acad Sci USA 96:6336\u20136340","journal-title":"Proc Natl Acad Sci U S A"},{"key":"76_CR14","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1172\/JCI9177","volume":"105","author":"HN Lode","year":"2000","unstructured":"Lode HN, Xiang R, Pertl U, Forster E, Schoenberger SP, Gillies SD, Reisfeld RA (2000) Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40\/CD40L interaction. J Clin Invest 105:1623\u20131630","journal-title":"J Clin Invest"},{"key":"76_CR15","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.169.9.5236","volume":"169","author":"FE Lund","year":"2002","unstructured":"Lund FE, Partida-Sanchez S, Lee BO, Kusser KL, Hartson L, Hogan RJ, Woodland DL, Randall TD (2002) Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza. J Immunol 169:5236\u20135243","journal-title":"J Immunol"},{"key":"76_CR16","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.4049\/jimmunol.163.3.1584","volume":"163","author":"M Matsumoto","year":"1999","unstructured":"Matsumoto M, Iwamasa K, Rennert PD, Yamada T, Suzuki R, Matsushima A, Okabe M, Fujita S, Yokoyama M (1999) Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-alpha-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis. J Immunol 163:1584\u20131591","journal-title":"J Immunol"},{"key":"76_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-2478(93)90169-3","volume":"39","author":"M Naramura","year":"1993","unstructured":"Naramura M, Gillies SD, Mendelsohn J, Reisfeld RA, Mueller BM (1993) Mechanisms of cellular cytotoxicity mediated by a recombinant antibody-IL2 fusion protein against human melanoma cells. Immunol Lett 39:91\u201399","journal-title":"Immunol Lett"},{"key":"76_CR18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1084\/jem.189.2.403","volume":"189","author":"VN Ngo","year":"1999","unstructured":"Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG (1999) Lymphotoxin alpha\/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 189:403\u2013412","journal-title":"J Exp Med"},{"key":"76_CR19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4049\/jimmunol.152.1.96","volume":"152","author":"R Schmandt","year":"1994","unstructured":"Schmandt R, Hill M, Amendola A, Mills GB, Hogg D (1994) IL-2-induced expression of TTK, a serine, threonine, tyrosine kinase, correlates with cell cycle progression. J Immunol 152:96\u2013105","journal-title":"J Immunol"},{"key":"76_CR20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1074-7613(01)00094-2","volume":"14","author":"D Schrama","year":"2001","unstructured":"Schrama D, thor Straten P, Fischer WH, McLellan AD, Br\u00f6cker EB, Reisfeld RA, Becker JC (2001) Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 14:111\u2013121","journal-title":"Immunity"},{"key":"76_CR21","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.4049\/jimmunol.172.10.5843","volume":"172","author":"D Schrama","year":"2004","unstructured":"Schrama D, Xiang R, Eggert AO, Andersen MH, Pedersen Ls LO, Kampgen E, Schumacher TN, Reisfeld RR, Becker JC (2004) Shift from systemic to site-specific memory by tumor-targeted IL-2. J Immunol 172:5843\u20135850","journal-title":"J Immunol"},{"key":"76_CR22","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1128\/JVI.76.8.3943-3951.2002","volume":"76","author":"M Suresh","year":"2002","unstructured":"Suresh M, Lanier G, Large MK, Whitmire JK, Altman JD, Ruddle NH, Ahmed R (2002) Role of lymphotoxin alpha in T-cell responses during an acute viral infection. J Virol 76:3943\u20133951","journal-title":"J Virol"},{"key":"76_CR23","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1073\/pnas.95.15.8785","volume":"95","author":"P Thor Straten","year":"1998","unstructured":"Thor Straten P, Guldberg P, Seremet T, Reisfeld RA, Zeuthen J, Becker JC (1998) Activation of preexisting T cell clones by targeted interleukin 2 therapy. Proc Natl Acad Sci USA 95:8785\u20138790","journal-title":"Proc Natl Acad Sci USA"},{"key":"76_CR24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.190.5.629","volume":"190","author":"Q Wu","year":"1999","unstructured":"Wu Q, Wang Y, Wang J, Hedgeman EO, Browning JL, Fu YX (1999) The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J Exp Med 190:629\u2013638","journal-title":"J Exp Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0076-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-005-0076-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0076-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T11:57:29Z","timestamp":1683201449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-005-0076-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,13]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s00262-005-0076-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,13]]}}}